Epidemiological studies in mucus hypersecretion

Novartis Foundation Symposium

Volumn 248, Issue , 2002, Pages 3-19

  Vestbo, Jørgen ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BIOLOGICAL MODEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; EXOCRINE GLAND; EXOCYTOSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; MIDDLE AGED; MORTALITY; MUCUS; OCCUPATIONAL DISEASE; PATHOPHYSIOLOGY; RESPIRATORY TRACT DISEASE; REVIEW; RISK; RISK FACTOR; SECRETION;

ADULT; AGED; COHORT STUDIES; EXOCRINE GLANDS; EXOCYTOSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MUCUS; OCCUPATIONAL DISEASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT DISEASES; RISK; RISK FACTORS; SECRETORY RATE;

EID: 0037674024     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (28)

1. Annesi I, Kauffmann F 1986 Is respiratory mucus hypersecretion really an innocent disorder? A 22-year mortality survey of 1061 working men. Am Rev Respir Dis 134:688-693
2. Ciba Foundation 1959 Terminology, definitions and classification of chronic pulmonary emphysema and related conditions. Thorax 14:286-299
3. Ebi-Kryston KL 1988 Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall study. J Clin Epidemiol 41:251-260
4. Ebi-Kryston KL 1989 Predicting 15 year chronic bronchitis mortality in the Whitehall Study. J Epidemiol Community Health 43:168-172
5. Fletcher C, Peto R 1977 The natural history of chronic airflow obstruction. Br Med J 1:1645-1648
6. Fletcher CM, Peto R, Tinker C, Speizer FE 1976 The natural history of chronic bronchitis and emphysema. Oxford University Press, Oxford
7. Higgins MW, Keller JB, Becker M et al 1982 An index of risk for obstructive airways disease. Am Rev Respir Dis 125:144-151
8. 1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Grit Care Med 164:358-364
9. Kauffmann F, Drouet D, Lellouch J, Brille D 1979 Twelve years spirometric changes among Paris area workers. Int J Epidemiol 8:201-212
10. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P 1990 Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 45:579-585
11. Lange P, Ulrik CS, Vestbo J 1996 Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. Lancet 347:1285-1289
12. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G 1998 A 15-year follow-up of ventilatory function in adults with asthma. N Eng J Med 339:1194-1200
13. Medical Research Council 1960 Standardized questionnaires on respiratory symptoms. Committee on the aetiology of chronic bronchitis. Br Med J 2:1665
14. Medical Research Council 1966 Instructions for the use of the questionnaire on respiratory symptoms. WJ Holman, Devon
15. Miravitlles M, Guerrero T, Mayordomo C, Sanchez-Agudo L, Nicolau F, Segu JL 2000 Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group. Respiration 67:495-501
16. Openshaw PJ, Turner-Warwick M 1989 Observations on sputum production in patients with variable airflow obstruction; Implications for the diagnosis of asthma and chronic bronchitis. Respir Med 83:25-31
17. Pauwels RA, Buist AS, Calverley PM, Jenkins CC, Hurd S 2001 Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/ WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 163:1256-1276
18. Peto R, Speizer FE, Cochrane AL et al 1983 The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis 128:491-500
19. Prescott E, Lange P, Vestbo J 1995 Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J 8:1333-1338
20. Pride NB, Burrows B 1995 Development of impaired lung function: natural history and risk factors. In: Calverley P, Pride NB (eds) Chronic obstructive pulmonary disease. Chapman & Hall, London p 69-91
21. Sherman CB, Xu X, Speizer FE, Ferris BG Jr, Weiss ST, Dockery DW 1992 Longitudinal lung function decline in subjects with respiratory symptoms. Am Rev Respir Dis 146:855-859
22. Speizer FE, Fay ME, Dockery DW, Ferris BG Jr 1989 Chronic obstructive pulmonary disease mortality in six U.S. cities. Am Rev Respir Dis 140:S49-S55
23. 1 as predictors of hospitalization and medication in the following 12 years due to respiratory disease. Eur Respir J 2:710-715
24. Vestbo J, Knudsen KM, Rasmussen FV 1989 The value of mucus hypersecretion as a predictor of mortality and hospitalization. An 11-year register based follow-up study of a random population sample of 876 men. Respir Med 83:207-211
25. 1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 153:1530-1535
26. Vestbo J, Lange P 2002 Can GOLD Stage O provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 166:329-332
27. Vollmer WM, McCamant LE, Johnson LR, Buist AS 1989 Respiratory symptoms, lung function, and mortality in a screening center cohort. Am J Epidemiol 129:1157-1169
28. Wiles FJ, Hnizdo E 1991 Relevance of airflow obstruction and mucus hypersecretion to mortality. Respir Med 85:27-35